The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies
Open accessAbstract
BACKGROUND: Endometriosis is a risk factor for epithelial ovarian cancer; however, whether this risk extends to all invasive histological subtypes or borderline tumours is not clear. We undertook an international collaborative study to assess the association between endometriosis and histological subtypes of ovarian cancer. METHODS: Data from 13 ovarian cancer case-control studies, which were part of the Ovarian Cancer Association Consortium, were pooled and logistic regression analyses were undertaken to assess the association between self-reported endometriosis and risk of ovarian cancer. Analyses of invasive cases were done with respect to histological subtypes, grade, and stage, and analyses of borderline tumours by histological subtype. Age, ethnic origin, study site, parity, and duration of oral contraceptive use were included in all analytical models. FINDINGS: 13 226 controls and 7911 women with invasive ovarian cancer were included in this analysis. 818 and 738, respectively, reported a history of endometriosis. 1907 women with borderline ovarian cancer were also included in the analysis, and 168 of these reported a history of endometriosis. Self-reported endometriosis was associated with a significantly increased risk of clear-cell (136 [20·2%] of 674 cases vs 818 [6·2%] of 13 226 controls, odds ratio 3·05, 95% CI 2·43-3·84, p<0·0001), low-grade serous (31 [9·2%] of 336 cases, 2·11, 1·39-3·20, p<0·0001), and endometrioid invasive ovarian cancers (169 [13·9%] of 1220 cases, 2·04, 1·67-2·48, p<0·0001). No association was noted between endometriosis and risk of mucinous (31 [6·0%] of 516 cases, 1·02, 0·69-1·50, p=0·93) or high-grade serous invasive ovarian cancer (261 [7·1%] of 3659 cases, 1·13, 0·97-1·32, p=0·13), or borderline tumours of either subtype (serous 103 [9·0%] of 1140 cases, 1·20, 0·95-1·52, p=0·12, and mucinous 65 [8·5%] of 767 cases, 1·12, 0·84-1·48, p=0·45). INTERPRETATION: Clinicians should be aware of the increased risk of specific subtypes of ovarian cancer in women with endometriosis. Future efforts should focus on understanding the mechanisms that might lead to malignant transformation of endometriosis so as to help identify subsets of women at increased risk of ovarian cancer. FUNDING: Ovarian Cancer Research Fund, National Institutes of Health, California Cancer Research Program, California Department of Health Services, Lon V Smith Foundation, European Community's Seventh Framework Programme, German Federal Ministry of Education and Research of Germany, Programme of Clinical Biomedical Research, German Cancer Research Centre, Eve Appeal, Oak Foundation, UK National Institute of Health Research, National Health and Medical Research Council of Australia, US Army Medical Research and Materiel Command, Cancer Council Tasmania, Cancer Foundation of Western Australia, Mermaid 1, Danish Cancer Society, and Roswell Park Alliance Foundation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“endometrioid cancer (OR 2.21)”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“It is becoming clear that epigenetics and genomic instability associated with the particular microenvironment of endometriosis characterized by oxidative stress, inflammatory process and high estrogen levels contribute to the process of malignant transformation of endometriosis (Pearce et al., 2012, Nezhat et al., 2014).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al., 2012
In the citing paper
“and low-grade serous invasive ovarian cancers (OR 2.21).”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. (2012), concluded that self-reported endometriosis was associated with significantly increased risk for CCC [odds ratio (OR) 3.05]”
From Clear cell carcinoma arising from abdominal wall endometriosis – Brief report and review of the literature (2017) · cites this paper as Pearce et al. (2012)
In the citing paper
“Pearce et al. summarized 13 case-control studies and reported the highest odds ratio of 3.05 for clear cell carcinoma, followed by LG-serous (2.11) and endometrioid carcinoma (2.04) in patients with endometriosis [9].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Malignant transformation of ovarian endometriosis has been well documented.”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“In population-based studies, the incidence of ovarian cancer in patients with a history of ovarian endometriosis is 1.35-1.49times greater compared with those without this history [9,10].”
From Malignancies Associated with Extraovarian Endometriosis: A Literature Review (2021) · cites this paper as [9]
In the citing paper
“Of these, we observed associations with multiple diseases or traits, including epithelial ovarian cancer21, low-density lipoprotein cholesterol22, coronary heart disease23, luteinizing hormone and follicle-stimulating hormone levels, and age at onset for menopause24.”
From Meta-analysis identifies five novel loci associated with endometriosis highlighting key genes involved in hormone metabolism (2017) · cites this paper as [21]
In the citing paper
“Most recently, in a study of 13 226 controls and 7911 women with invasive ovarian cancer, self-reported endometriosis was associated with a significantly increased risk of clear-cell, low-grade serous, and endometrioid invasive ovarian cancers.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“No association was noted between endometriosis and risk of mucinous or high-grade serous invasive ovarian cancer or borderline tumors of either subtype.118”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“Endometriosis and ovarian cancer have been linked by a number of studies.”
From Defining Future Directions for Endometriosis Research: Workshop Report From the 2011 World Congress of Endometriosis in Montpellier, France (2013) · cites this paper as [118]
In the citing paper
“which have been (suggested to be) associated with endometriosis or its constituting symptoms in epidemiologic studies (51–54).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,890
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Self-citationEskenazi, B., & Warner, M. L. (1997) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70302-8 · Cited by 1,617
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
Kurman, R. J., & Shih, I. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.03.003 · Cited by 1,099
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Bradburn, M. J., Deeks, J. J., Berlin, J. A., & Russell Localio, A. (2007) · Statistics in Medicine · doi:10.1002/sim.2528 · Cited by 938
Ovarian Tumors in a Cohort of Infertile Women
Rossing, M. A., Daling, J. R., Weiss, N. S., Moore, D. E., & Self, S. G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311204 · Cited by 721
Self-citationCancer risk after a hospital discharge diagnosis of endometriosis
Brinton, L. A., Gridley, G., Persson, I. R., Baron, J. A., & Bergqvist, A. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70550-7 · Cited by 549
Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies
Ness, R. B. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.3.217 · Cited by 425
Self-citationRisk of cancer after use of fertility drugs with in-vitro fertilisation
Venn, A., Watson, L., Bruinsma, F., Giles, G. G., & Healy, D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05203-4 · Cited by 368
Endometriosis and the risk of cancer with special emphasis on ovarian cancer
Melin, A., Sparén, P., Persson, I., & Bergqvist, A. (2006) · Human Reproduction · doi:10.1093/humrep/dei462 · Cited by 306
Cited by
Sorted by citations
Items 601–700 of 946
Liu, J., Ma, Y., Jiang, W. G., & Xie, P. (2024) · Medicine · doi:10.1097/md.0000000000040131 · Cited by 6
Zhao, Y., & Jiang, Y. (2022) · OncoTargets and Therapy · doi:10.2147/ott.s362267 · Cited by 6
Wuntakal, R., & Lawrence, A. C. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.11.021 · Cited by 6
Epidemiological trends of hormone-related cancers in Slovenia
Zadnik, V., & Krajc, M. (2016) · Archives of Industrial Hygiene and Toxicology · doi:10.1515/aiht-2016-67-2731 · Cited by 6
Brüggmann, D., Louwen, F., Braun, T., Klingelhöfer, D., Bauer, J., Bendels, M. H. K., Bundschuh, M., Quarcoo, D., Jaque, J. M., Wanke, E. M., et al. (2017) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2017.10.112 · Cited by 6
Ovarian Clear Cell Carcinoma: From Morphology to Molecular Biology
Improta, G., Pettinato, A., Høgdall, E. V. S., Santeusanio, G., Vatrano, S., Fraggetta, F., & Zannoni, G. F. (2018) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000662 · Cited by 6
Identification of potential key genes associated with ovarian clear cell carcinoma
Xu, Y., & Shen, K. (2018) · Cancer Management and Research · doi:10.2147/cmar.s187156 · Cited by 6
RetractedMetachronous occurrence of two different histological subtypes of endometriosis-related neoplasms
Uehara, T., Yoshida, H., Tate, K., & Kato, T. (2018) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2018.12.007 · Cited by 6
Common Analgesic Use for Menstrual Pain and Ovarian Cancer Risk
Sasamoto, N., Babić, A., Vitonis, A. F., Titus, L. J., Cramer, D. W., Trabert, B. L., Tworoger, S. S., & Terry, K. L. (2021) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-21-0090 · Cited by 6
Self-citationPromising therapeutic targets of endometriosis obtained from microRNA studies
Nasu, K., Aoyagi, Y., Zhu, R., Okamoto, M., Kai, K., & Kawano, Y. (2021) · Medical Molecular Morphology · doi:10.1007/s00795-021-00308-3 · Cited by 6
Younis, J. S., & Izhaki, I. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1193123 · Cited by 6
Brinton, L. A. (2017) · Seminars in Reproductive Medicine · doi:10.1055/s-0037-1603098 · Cited by 6
Pathogenesis, Genetics, and Genomics of Non–High Grade Serous Ovarian Cancers
Ilenkovan, N., & Gourley, C. (2018) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2018.07.004 · Cited by 6
How Benign is Endometriosis: Multi-Scale Interrogation of Documented Evidence
Ghosh, D., Geethadevi, A., Bhat, M. A., Bharti, J. N., Mridha, A., Jb, S., Kk, R., & Sengupta, J. (2019) · Current Opinion in Gynecology and Obstetrics · doi:10.18314/cogo.v2i1.1840 · Cited by 6
Systemic therapy for non-serous ovarian carcinoma
Chávarri-Guerra, Y., González-Ochoa, E., de la Mora‐Molina, H., & Soto‐Pérez‐de‐Celis, E. (2020) · Chinese Clinical Oncology · doi:10.21037/cco-20-36 · Cited by 6
Uterine clear cell carcinoma arising from cystic adenomyosis: a case report
Gomez, N. F., Still, M. A., Akki, A. S., Carbajal-Mamani, S. L., & Cardenas-Goicoechea, J. (2021) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2020.1847056 · Cited by 6
Rozenberg, S., Antoine, C., Vandromme, J., & Fastrez, M. (2015) · Climacteric · doi:10.3109/13697137.2015.1041905 · Cited by 6
Ye, L., Chen, J., Guo, W., Zhao, Q., Cheng, X., Wang, X., Xu, X., Chen, X., & Ni, J. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2583543 · Cited by 5
Therapeutic targeting of interleukin-17C signaling in carcinogenesis of endometriosis
Yao, B., Zheng, R., Yang, Y., Zhao, Z., Lash, G. E., Guo, B., Pan, J., Shuai, H., Zhou, H. K., Wang, M., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102464 · Cited by 5
Wei, N., Guan, H., Zhang, Y., Shi, J., Ma, J., Shi, R., Qi, X., Dong, Z., & Zhao, R. (2025) · Biomedical Reports · doi:10.3892/br.2025.2030 · Cited by 5
Spagnolo, E., Martínez, A., Mascarós-Martínez, A., Marí‐Alexandre, J., Carbonell, M., González-Cantó, E., Pena‐Burgos, E. M., Cormack, B. A. M., Tomás-Pérez, S., Gilabert–Estellés, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512083 · Cited by 5
Wang, D., Ran, X., He, Y. J., Zhu, L., & Deng, Y. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15263 · Cited by 5
Expression of HIF-1α, Ki67, SMA and E-cadherin in endometriosis, endometrial and ovarian carcinoma
Markov, D., Poryazova, E. G., Raycheva, R., & Markov, G. (2024) · Folia Medica · doi:10.3897/folmed.66.e112757 · Cited by 5
Sadati, S. A., Chekini, Z., Shekari, F., Hafezi, M., Ghaheri, A., Shahhoseini, M., Moini, A., Aflatonian, R., Totonchi, M., & Afsharian, P. (2025) · Scientific Reports · doi:10.1038/s41598-025-09660-1 · Cited by 5
Tashima, L., Hori, K., Ono, H., Nagano, T., Nakatsuka, S., & Ito, K. (2017) · International Journal of Surgery Case Reports · doi:10.1016/j.ijscr.2017.10.034 · Cited by 5
Taylor, R. N., & Lebovic, D. I. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2758-2.00026-3 · Cited by 6
Ciliated Carcinoma of the Endometrium
Guerrieri, C., Anderson, P., & Hudacko, R. M. (2020) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0000000000000686 · Cited by 5
Wang, T., Zeng, J., Li, N., Zhang, R., Song, Y., & Wu, L. (2020) · PubMed Central · Cited by 5
Insights into molecular pathways of endometriosis and endometriosis-related ovarian carcinoma
Păvăleanu, I., Lozneanu, L., Balan, R. A., Giuşcă, S. E., Avădănei, E.-R., Căruntu, I.-D., & Amălinei, C. (2021) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.61.3.12 · Cited by 5
Wang, X., Tang, G., Guo, H., Ma, J., Liu, D., Wang, Y., Jin, R., Li, Z., & Tang, Y. (2023) · Natural Product Communications · doi:10.1177/1934578x231161414 · Cited by 5
Associations between TAB2 Gene Polymorphisms and Epithelial Ovarian Cancer in a Chinese Population
Huang, X., Shen, C., Zhang, Y., Li, Q., Li, K., Wang, Y., Song, Y., Su, M., Zhou, B., & Wang, W. (2019) · Disease Markers · doi:10.1155/2019/8012979 · Cited by 5
Translational Applications of Linear and Circular Long Noncoding RNAs in Endometriosis
Wang, X., Parodi, L., & Hawkins, S. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910626 · Cited by 5
Neoplasms in the trocar site and peritoneal papillary serous cystadenocarcinoma
Lai, C., Yen, M., & Wang, P. (2014) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2014.04.002 · Cited by 5
New Insights in Endometriosis Subtypes and Ovarian Cancer Risk
McHale, M. T. (2024) · JAMA · doi:10.1001/jama.2024.12357 · Cited by 5
Witham, M., & Hengel, S. R. (2024) · NAR Molecular Medicine · doi:10.1093/narmme/ugae010 · Cited by 6
Cell Migration in Endometriosis Responds to Omentum-Derived Molecular Cues Similar to Ovarian Cancer
Goh, K. Y., Tham, S. C., Cheng, T. Y. D., Nadarajah, R., Goh, R. C. H., Wong, S. L., Ho, T. H., Chew, G. K., Tan, A. W. K., Rajesh, H., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051822 · Cited by 4
Epithelial characteristics of ovarian clear cell carcinoma at single-cell resolution
Guo, Q., Chen, X., Bi, R., Li, H., Liu, M., Ju, X., Feng, Z., Zhu, J., Li, Y., Wang, X., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08617-4 · Cited by 4
Chung, Y. S., Shim, J. E., Baek, J. K., Choi, E., Kim, H., Yun, B. H., & Seo, S. K. (2025) · Yonsei Medical Journal · doi:10.3349/ymj.2024.0518 · Cited by 4
Endometriosis apendicular. Nuestra experiencia en los últimos 11 años
Vázquez, C. C., Marcacuzco, A., Municio, A. M., Justo, I., Maestro, Ó. C., Calvo, J., Delgado, M., Nutu, O. A., & Jiménez‐Romero, C. (2017) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/j.gine.2017.03.003 · Cited by 4
McLean, K., & Mehta, G. (2017) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000001119 · Cited by 4
Rokhgireh, S., Mehdizadehkashi, A., Tahermanesh, K., & Gorginzadeh, M. (2019) · World Journal of Obstetrics and Gynecology · doi:10.5317/wjog.v8.i2.8 · Cited by 4
Chen, C., Ren, W., Pei, L., Sun, J., & Bai, T. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-2351 · Cited by 4
Ayhan, A., Akıllı, H., & Haberal, N. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-4935-x · Cited by 4
The Association of Endometriosis with Ovarian Cancer: A Critical Review of Epidemiological Data
Guo, S. (2014) · Springer eBooks · doi:10.1007/978-4-431-54421-0_22 · Cited by 4
Surgery of abdominal wall endometriosis associated with clear-cell carcinoma: Case report and review
Petit, C., Donval, L., Chandeze, M.-M., Chis, C., Joste, M., & Panel, P. (2023) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2023.102561 · Cited by 4
Meinhold-Heerlein, I. M., Zeppernick, M. M., Wölfler, M. M., Janschek, E., Bornemann, S., Holtmann, L., Oehmke, F., Salehin, D., Scheible, C. M., Brandes, I., et al. (2023) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-2061-6845 · Cited by 4
Borghese, B., Santulli, P., Vaiman, D., Alexandre, J., Goldwasser, F., & Chapron, C. (2013) · Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément/Journal de gynécologie obstétrique et biologie de la reproduction · doi:10.1016/j.jgyn.2013.02.013 · Cited by 4
Tranoulis, A., Buruiana, F. E., Gupta, B., Kwong, A., Lakhiani, A., Yap, J. K. W., Balega, J., & Singh, K. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06191-8 · Cited by 4
Butler, H., Saulat, O., & Guinn, B. (2022) · Carcinogenesis · doi:10.1093/carcin/bgac012 · Cited by 4
Genomic Insults and their Redressal in the Eutopic Endometrium of Women with Endometriosis
Munshi, I., & Sachdeva, G. (2023) · Reproductive Medicine · doi:10.3390/reprodmed4020009 · Cited by 4
Yin, M., Lu, C., Zhou, H., Liu, Q., & Yang, J. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02420-1 · Cited by 4
Endometriosis link to invasive subtypes
Ozerlat, I. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.31 · Cited by 4
Epigenetic control of endocrine disrupting chemicals on gynecological disease: Focused on phthalates
Cho, H. H. (2012) · Korean Journal of Obstetrics & Gynecology · doi:10.5468/kjog.2012.55.9.619 · Cited by 4
de la Guía, G. D. (2016) · Revista Colombiana de Obstetricia y Ginecología · doi:10.18597/rcog.385 · Cited by 4
Endometriosis and risk of ovarian cancer
Kornovski, Y. D., Atanasova, Y., Kostov, S. G., Slavchev, S. H., & Yordanov, A. D. (2021) · Oncology in Clinical Practice · doi:10.5603/ocp.2021.0012 · Cited by 4
Is Endometriosis a Preneoplastic Condition?
Demirkıran, F. (2015) · Women s Health · doi:10.2217/whe.15.57 · Cited by 4
Patriotis, C., Simmons, A. R., Lu, K. H., Bast, R. C., & Skates, S. J. (2017) · Wiley eBooks · doi:10.1002/9781118468869.ch8 · Cited by 4
Lin, P., Wu, L., Lai, X., Xiao, C., & Ye, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-03587-9 · Cited by 3
Guideline No. 468: Clinical Management of Endometriosis
Yong, P. J., Allaire, C., Bedaiwy, M. A., Bougie, O., Kives, S. L., Maheux‐Lacroix, S., Murji, A., Singh, S. S., Amoako, E., Bajzak, D. K., et al. (2026) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2026.103382 · Cited by 3
Piacenti, I., Tius, V., Gomba, B., Restaino, S., Arcieri, M., Zermano, S., Biasioli, A., Perelli, F., Raimondo, D., Lazzeri, L., et al. (2026) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2026.04.021 · Cited by 3
Zhao, L., Liu, Y., Liu, F., Jin, X., Xu, J., Zhou, S., Meng, Y., Liu, A., & Yang, W. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1280529 · Cited by 3
Song, Y., Wang, L., & Zhang, Y. (2023) · Medicine · doi:10.1097/md.0000000000036707 · Cited by 3
Zhang, X., Wang, L., Ruan, X., Ding, J., Wan, J., Xu, C., & Li, X. (2025) · Discover Oncology · doi:10.1007/s12672-025-03387-1 · Cited by 3
Primary Ovarian Endometrioid Adenocarcinoma
Li, H., Qiang, J., Xia, G. L., Zhao, S. H., Feng, H., Cai, S., Feng, F., & Fu, A. Y. (2015) · Journal of Computer Assisted Tomography · doi:10.1097/rct.0000000000000210 · Cited by 3
Endometriosis: When and How We Treat
Saceanu, S., Pătrașcu, Ș., Pătraşcu, A., & Surlin, V. (2017) · InTech eBooks · doi:10.5772/65296 · Cited by 3
Rahmioğlu, N., Fassbender, A., Vitonis, A. F., Hummelshøj, L., Adamson, G. D., Becker, C. M., Missmer, S. A., & Zondervan, K. T. (2017) · Springer eBooks · doi:10.1007/978-3-319-59856-7_11 · Cited by 3
Self-citationZachaki, S., Kalomoiraki, M., Kouvidi, E., Promponas, E., Syrkos, S., Panopoulou, B., Pantou, A., Mavrou, A., Kanavakis, E., & Manola, K. N. (2021) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2021.07.028 · Cited by 3
Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk
Lee, A. W., Ness, R. B., Roman, L. D., Terry, K. L., Schildkraut, J. M., Chang‐Claude, J., Doherty, J. A., Menon, U., Cramer, D. W., Gayther, S. A., et al. (2016) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000489579.62561.b8 · Cited by 3
Self-citationLong, L., & Duan, Z. (2022) · BioMed Research International · doi:10.1155/2022/8338874 · Cited by 3
Skarga, E., Surcel, H., Kaaks, R., Waterboer, T., & Fortner, R. T. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad171 · Cited by 3
Küpker, W., Aizpurúa, J., Felberbaum, R. E., & Diedrich, K. (2024) · Die Gynäkologie · doi:10.1007/s00129-024-05203-3 · Cited by 3
Zhao, K., Hu, M., Li, X., Yang, R., & Huang, Y. (2024) · Oncology Letters · doi:10.3892/ol.2024.14656 · Cited by 3
You, W., Wang, S., Li, C., Ma, Y., Liu, F.-Y., Shen, Y., Wang, Y., Wan, F., & Han, F. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70046 · Cited by 3
Endometrioseassoziierte maligne Tumoren
Ulrich, U. A., Wunschel, A., Reichert, V. M., Darb‐Esfahani, S., Denschlag, D., Horn, L., NOACK, F., Renner, S. P., Sillem, M., Schweppe, K.-W., et al. (2015) · Der Gynäkologe · doi:10.1007/s00129-014-3424-y · Cited by 3
Prise en charge des endométriomes
Chauvet, P., Roman, H., Grémeau, A., Canis, M. J., & Bourdel, N. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.10.004 · Cited by 3
Endometriosis: The Enigma That It Continues to Be
Sharma, S., & Tripathi, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.108774 · Cited by 3
Batista, M. D. P., Roffé, M., Romero, I., López‐Guerrero, J. A., Illueca, C., López-Reig, R., da Costa, A. A. B. A., Brot, L. D., Molina, J. P., Barboza, L., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-11095-8 · Cited by 3
Waluyo, S. T., & Tjokroprawiro, B. A. (2023) · Bali Medical Journal · doi:10.15562/bmj.v12i1.3983 · Cited by 3
The diagnosis of endometriosis with the help of mass spectrometry (a review)
Borisova, A. V., Kozachenko, K. A. V., Starodubtseva, N. L., Бугрова, А. Е., Евгеньевич, Ф. В., & Adamjan, L. V. (2015) · Russian Journal of Human Reproduction · doi:10.17116/repro201521659-68 · Cited by 3
Uehara, T., Yoshida, H., & Kato, T. (2020) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2020.100692 · Cited by 3
Endometriosis and an increased risk of malignancies
Krasa, A. M., Kozioł, M., Piecewicz‐Szczęsna, H., Pawlicki, M., Łopuszyńska, A. M., KRAWIEC, P., & Piekarska, E. (2020) · Journal of Education Health and Sport · doi:10.12775/jehs.2020.10.09.033 · Cited by 3
The Basic Science of Endometriosis
Yong, P. J. (2020) · Wiley eBooks · doi:10.1002/9781119482598.ch33 · Cited by 3
Exosomal miRNAs as novel potential biomarkers for endometriosisPreprint
Zhang, L., Liu, H., Zhu, L., Luo, H.-J., Chen, X., Yu, G.-Y., Li, Q., & Jin, P. (2020) · Research Square · doi:10.21203/rs.3.rs-56647/v1 · Cited by 3
Prueksaritanond, N., Petchsila, K., & Insin, P. (2024) · World Journal of Oncology · doi:10.14740/wjon1963 · Cited by 2
Causal role of ischemic heart disease in ovarian cancer subtypes
Chen, J., He, H., & Gao, L. (2025) · Discover Oncology · doi:10.1007/s12672-025-01824-9 · Cited by 2
Yuan, M., Chen, S., Liao, Z., & Wang, K. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1450892 · Cited by 2
Kloeckner, A. A., & Walker, S. R. (2025) · Cells · doi:10.3390/cells14100742 · Cited by 2
Fu, Z., Borho, L., Taylor, S. E., Kelemen, L. E., DeFazio, A., Webb, P. M., Köbel, M., Meagher, N. S., Na, R., Antoniou, A. C., et al. (2025) · Gynecologic Oncology · doi:10.1016/j.ygyno.2025.05.013 · Cited by 2
Self-citationIyoshi, S., Emoto, R., Yoshikawa, N., Yoshida, K., Yoshihara, M., Tamauchi, S., Yokoi, A., Shimizu, Y., Ikeda, Y., Niimi, K., et al. (2025) · Cancer Medicine · doi:10.1002/cam4.71118 · Cited by 2
Deep infiltrating endometriosis: retroperitoneal endometriosis-a case report
Xu, H., Qian, H., Zheng, Y., Ma, R., Zhao, R., & Chen, J. (2025) · BMC Women s Health · doi:10.1186/s12905-025-03981-z · Cited by 2
Wu, L., Su, R., Jia, J., Kuang, Z., Zeng, C., & Pei, F. (2026) · Hereditas · doi:10.1186/s41065-026-00637-2 · Cited by 2
Beck, M. H., Kordowitzki, P., Roser, E., Trelinska-Finger, A., Schoof, E., Chinczewski, L., Mechsner, S., & Sehouli, J. (2026) · BMC Cancer · doi:10.1186/s12885-026-15980-w · Cited by 2
Bahrami, F., McLeod, J., Pearce, C. L., Kushi, L. H., Garcia, C., Yong, P. J., Vera, M. A. D., McAlpine, J. N., Gamez, J. N. B., Tischer, K. M., et al. (2026) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djag251 · Cited by 2
Self-citationUsing Raman Spectroscopy to Investigate the Molecular Level Characteristics of Endometriosis
Akyüz, S., Çeli̇k, S., Usta, A. T., Özel, A. E., Yılmaz, G., & Yılmaz, S. (2020) · Optics and Spectroscopy · doi:10.1134/s0030400x20080044 · Cited by 2
Charatsingha, R., Hanamornroongruang, S., Benjapibal, M., Therasakvichya, S., Jaishuen, A., Chaopotong, P., Srichaikul, P., & Jareemit, N. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06096-6 · Cited by 2
Du, Y., Hu, Y., Zhang, F., Guan, Y., & Sheng, Y. (2023) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15720 · Cited by 2
Drasin, M., Rumore, G. J., & Suh‐Burgmann, E. (2023) · Current Problems in Cancer Case Reports · doi:10.1016/j.cpccr.2023.100254 · Cited by 2
Endometriosis and Endometriosis-Associated Tumors
Simmen, R. C. M., Quick, C. M., & Zheng, W. (2024) · Springer eBooks · doi:10.1007/978-981-19-7696-4_12-1 · Cited by 2
Liu, J., Bao, R.-H., Luan, M., Liu, C., Wu, L., Liu, F.-H., Li, Y.-Z., Xu, H.-L., Wei, Y., Xiao, Q., et al. (2025) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2025.02.008 · Cited by 2
Clearing the Path for Immunologic Targeting of Gynecologic Clear Cell Carcinomas
Drew, Y., & Bookman, M. A. (2025) · JAMA Oncology · doi:10.1001/jamaoncol.2025.1855 · Cited by 2
Metadata
- Authors
- Pearce, C. L., Templeman, C., Rossing, M. A., Lee, A., Near, A. M., Webb, P. M., Nagle, C. M., Doherty, J. A., Cushing-Haugen, K. L., Wicklund, K. G., Chang-Claude, J., Hein, R., Lurie, G., Wilkens, L. R., Carney, M. E., Goodman, M. T., Moysich, K., Kjaer, S. K., Hogdall, E., Jensen, A., Goode, E. L., Fridley, B. L., Larson, M. C., Schildkraut, J. M., Palmieri, R. T., Cramer, D. W., Terry, K. L., Vitonis, A. F., Titus, L. J., Ziogas, A., Brewster, W., Anton-Culver, H., Gentry-Maharaj, A., Ramus, S. J., Anderson, A. R., Brueggmann, D., Fasching, P. A., Gayther, S. A., Huntsman, D. G., Menon, U., Ness, R. B., Pike, M. C., Risch, H., Wu, A. H., & Berchuck, A.
- Affiliations
- University of Southern California (US)
- Fred Hutch Cancer Center (US)
- Georgetown University Medical Center (US)
- QIMR Berghofer Medical Research Institute (AU)
- German Cancer Research Center (DE)
- University of Hawaiʻi at Mānoa (US)
- Roswell Park Comprehensive Cancer Center (US)
- Danish Cancer Society (DK)
- Mayo Clinic (US)
- Duke Medical Center (US)
- Brigham and Women's Hospital (US)
- Dartmouth College (US)
- University of California, Irvine (US)
- University of North Carolina at Chapel Hill (US)
- University College London (GB)
- University of California, Los Angeles (US)
- Yale University (US)
- Corresponding author
- Pearce, Celeste Leigh
- ORCID
- Pearce, Celeste Leigh
- Lee, Alice
- Near, Aimee M
- Webb, Penelope M
- Nagle, Christina M
- Doherty, Jennifer A
- Wicklund, Kristine G
- Wilkens, Lynne R
- Goodman, Marc T
- Moysich, Kirsten
- Jensen, Allan
- Goode, Ellen L
- Fridley, Brooke L
- Larson, Melissa C
- Schildkraut, Joellen M
- Cramer, Daniel W
- Terry, Kathryn L
- Titus, Linda J
- Ziogas, Argyrios
- Brewster, Wendy
- Ramus, Susan J
- Fasching, Peter A
- Gayther, Simon A
- Menon, Usha
- Pike, Malcolm C
- Risch, Harvey
- Wu, Anna H
- Berchuck, Andrew
- Venue
- The Lancet Oncology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 13
- Issue
- 4
- Pages
- 385-394
- ISSN
- 1470-2045 (ISSN-L)
- PMC
- PMC3664011
- OpenAlex
- W2125681453
- Cited by
- 939
- References
- 43
- Citations by year
- 2026: 47 · 2025: 53 · 2024: 46 · 2023: 64 · 2022: 44 · 2021: 84 · 2020: 88 · 2019: 77 · 2018: 71 · 2017: 83 · 2016: 68 · 2015: 65 · 2014: 55 · 2013: 68 · 2012: 26
- FWCI
- 79.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Lancet Oncology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- California Breast Cancer Research Program (0001389V20170, 2110200)
- Seventh Framework Programme (HEALTH-F2-2009-223175)
- University of South China
- National Institutes of Health (5R01 CA074850, CA14089, CA17054, CA58860, CA61132, CA92044, N01 CN67001, N01 PC35137, N01 PC67010, P50 CA105009, P50 CA136393, PSA 042205, R01 CA112523, R01 CA122443, R01 CA126841, R01 CA136891, R01 CA54419, R01 CA58598, R01 CA61107, R01 CA76016, R01 CA87538, R01 CA95023, R03 CA113148)
- Medical Research and Materiel Command (DAMD 170110729, DAMD17-02-1-0669, W81XWH0610220, W81XWH1010280)
- Oak Foundation
- Lon V. Smith Foundation (LVS 39420)
- California Department of Public Health (050E8709)
- Roswell Park Alliance Foundation, Roswell Park Cancer Institute
- Kræftens Bekæmpelse
- Deutsches Krebsforschungszentrum
- National Health and Medical Research Council (199600)
- Cancer Council Tasmania
- American University of Sharjah
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Keywords
- endometriosis, ovarian cancer, histological subtypes, ovarian clear cell carcinoma, low-grade serous ovarian cancer, endometrioid ovarian cancer, mucinous ovarian carcinoma, high-grade serous ovarian cancer, borderline ovarian tumors, cancer risk factors, oral contraceptive use, parity, tumor stage and grade, Ovarian Cancer Association Consortium
- MeSH terms
- Aged, Aged, 80 and over, Endometriosis, Ethnicity, Female, Humans, Middle Aged, Neoplasm Invasiveness, Neoplasm Staging, Ovarian Neoplasms, Risk Factors, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
